1 Study Coverage
    1.1 Tadalafil Oral Product Introduction
    1.2 Market by Type
        1.2.1 Global Tadalafil Oral Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 2.5 mg tablets
        1.2.3 5 mg tablets
        1.2.4 10mg tablets
        1.2.5 20 mg tablets
    1.3 Market by Application
        1.3.1 Global Tadalafil Oral Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Drug store
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Tadalafil Oral Sales Estimates and Forecasts 2017-2028
    2.2 Global Tadalafil Oral Revenue Estimates and Forecasts 2017-2028
    2.3 Global Tadalafil Oral Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Tadalafil Oral Sales by Region
        2.4.1 Global Tadalafil Oral Sales by Region (2017-2022)
        2.4.2 Global Sales Tadalafil Oral by Region (2023-2028)
    2.5 Global Tadalafil Oral Revenue by Region
        2.5.1 Global Tadalafil Oral Revenue by Region (2017-2022)
        2.5.2 Global Tadalafil Oral Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Tadalafil Oral Sales by Manufacturers
        3.1.1 Global Top Tadalafil Oral Manufacturers by Sales (2017-2022)
        3.1.2 Global Tadalafil Oral Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tadalafil Oral in 2021
    3.2 Global Tadalafil Oral Revenue by Manufacturers
        3.2.1 Global Tadalafil Oral Revenue by Manufacturers (2017-2022)
        3.2.2 Global Tadalafil Oral Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Tadalafil Oral Revenue in 2021
    3.3 Global Tadalafil Oral Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Tadalafil Oral Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Tadalafil Oral Sales by Type
        4.1.1 Global Tadalafil Oral Historical Sales by Type (2017-2022)
        4.1.2 Global Tadalafil Oral Forecasted Sales by Type (2023-2028)
        4.1.3 Global Tadalafil Oral Sales Market Share by Type (2017-2028)
    4.2 Global Tadalafil Oral Revenue by Type
        4.2.1 Global Tadalafil Oral Historical Revenue by Type (2017-2022)
        4.2.2 Global Tadalafil Oral Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Tadalafil Oral Revenue Market Share by Type (2017-2028)
    4.3 Global Tadalafil Oral Price by Type
        4.3.1 Global Tadalafil Oral Price by Type (2017-2022)
        4.3.2 Global Tadalafil Oral Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Tadalafil Oral Sales by Application
        5.1.1 Global Tadalafil Oral Historical Sales by Application (2017-2022)
        5.1.2 Global Tadalafil Oral Forecasted Sales by Application (2023-2028)
        5.1.3 Global Tadalafil Oral Sales Market Share by Application (2017-2028)
    5.2 Global Tadalafil Oral Revenue by Application
        5.2.1 Global Tadalafil Oral Historical Revenue by Application (2017-2022)
        5.2.2 Global Tadalafil Oral Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Tadalafil Oral Revenue Market Share by Application (2017-2028)
    5.3 Global Tadalafil Oral Price by Application
        5.3.1 Global Tadalafil Oral Price by Application (2017-2022)
        5.3.2 Global Tadalafil Oral Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Tadalafil Oral Market Size by Type
        6.1.1 North America Tadalafil Oral Sales by Type (2017-2028)
        6.1.2 North America Tadalafil Oral Revenue by Type (2017-2028)
    6.2 North America Tadalafil Oral Market Size by Application
        6.2.1 North America Tadalafil Oral Sales by Application (2017-2028)
        6.2.2 North America Tadalafil Oral Revenue by Application (2017-2028)
    6.3 North America Tadalafil Oral Market Size by Country
        6.3.1 North America Tadalafil Oral Sales by Country (2017-2028)
        6.3.2 North America Tadalafil Oral Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Tadalafil Oral Market Size by Type
        7.1.1 Europe Tadalafil Oral Sales by Type (2017-2028)
        7.1.2 Europe Tadalafil Oral Revenue by Type (2017-2028)
    7.2 Europe Tadalafil Oral Market Size by Application
        7.2.1 Europe Tadalafil Oral Sales by Application (2017-2028)
        7.2.2 Europe Tadalafil Oral Revenue by Application (2017-2028)
    7.3 Europe Tadalafil Oral Market Size by Country
        7.3.1 Europe Tadalafil Oral Sales by Country (2017-2028)
        7.3.2 Europe Tadalafil Oral Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Tadalafil Oral Market Size by Type
        8.1.1 Asia Pacific Tadalafil Oral Sales by Type (2017-2028)
        8.1.2 Asia Pacific Tadalafil Oral Revenue by Type (2017-2028)
    8.2 Asia Pacific Tadalafil Oral Market Size by Application
        8.2.1 Asia Pacific Tadalafil Oral Sales by Application (2017-2028)
        8.2.2 Asia Pacific Tadalafil Oral Revenue by Application (2017-2028)
    8.3 Asia Pacific Tadalafil Oral Market Size by Region
        8.3.1 Asia Pacific Tadalafil Oral Sales by Region (2017-2028)
        8.3.2 Asia Pacific Tadalafil Oral Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Tadalafil Oral Market Size by Type
        9.1.1 Latin America Tadalafil Oral Sales by Type (2017-2028)
        9.1.2 Latin America Tadalafil Oral Revenue by Type (2017-2028)
    9.2 Latin America Tadalafil Oral Market Size by Application
        9.2.1 Latin America Tadalafil Oral Sales by Application (2017-2028)
        9.2.2 Latin America Tadalafil Oral Revenue by Application (2017-2028)
    9.3 Latin America Tadalafil Oral Market Size by Country
        9.3.1 Latin America Tadalafil Oral Sales by Country (2017-2028)
        9.3.2 Latin America Tadalafil Oral Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Tadalafil Oral Market Size by Type
        10.1.1 Middle East and Africa Tadalafil Oral Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Tadalafil Oral Revenue by Type (2017-2028)
    10.2 Middle East and Africa Tadalafil Oral Market Size by Application
        10.2.1 Middle East and Africa Tadalafil Oral Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Tadalafil Oral Revenue by Application (2017-2028)
    10.3 Middle East and Africa Tadalafil Oral Market Size by Country
        10.3.1 Middle East and Africa Tadalafil Oral Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Tadalafil Oral Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eli Lilly Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eli Lilly Recent Developments
    11.2 Teva
        11.2.1 Teva Corporation Information
        11.2.2 Teva Overview
        11.2.3 Teva Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Teva Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Teva Recent Developments
    11.3 Aurobindo
        11.3.1 Aurobindo Corporation Information
        11.3.2 Aurobindo Overview
        11.3.3 Aurobindo Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Aurobindo Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Aurobindo Recent Developments
    11.4 Sun Pharma
        11.4.1 Sun Pharma Corporation Information
        11.4.2 Sun Pharma Overview
        11.4.3 Sun Pharma Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sun Pharma Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sun Pharma Recent Developments
    11.5 Alembic Pharmaceuticals
        11.5.1 Alembic Pharmaceuticals Corporation Information
        11.5.2 Alembic Pharmaceuticals Overview
        11.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Alembic Pharmaceuticals Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Alembic Pharmaceuticals Recent Developments
    11.6 Mylan
        11.6.1 Mylan Corporation Information
        11.6.2 Mylan Overview
        11.6.3 Mylan Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Mylan Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Mylan Recent Developments
    11.7 Accord Healthcare
        11.7.1 Accord Healthcare Corporation Information
        11.7.2 Accord Healthcare Overview
        11.7.3 Accord Healthcare Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Accord Healthcare Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Accord Healthcare Recent Developments
    11.8 Cipla
        11.8.1 Cipla Corporation Information
        11.8.2 Cipla Overview
        11.8.3 Cipla Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Cipla Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Cipla Recent Developments
    11.9 Ajanta Pharma Ltd.
        11.9.1 Ajanta Pharma Ltd. Corporation Information
        11.9.2 Ajanta Pharma Ltd. Overview
        11.9.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Ajanta Pharma Ltd. Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Ajanta Pharma Ltd. Recent Developments
    11.10 Dr. Reddys Laboratories
        11.10.1 Dr. Reddys Laboratories Corporation Information
        11.10.2 Dr. Reddys Laboratories Overview
        11.10.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Dr. Reddys Laboratories Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Dr. Reddys Laboratories Recent Developments
    11.11 Qilu Pharmaceutical
        11.11.1 Qilu Pharmaceutical Corporation Information
        11.11.2 Qilu Pharmaceutical Overview
        11.11.3 Qilu Pharmaceutical Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Qilu Pharmaceutical Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Qilu Pharmaceutical Recent Developments
    11.12 Lupin
        11.12.1 Lupin Corporation Information
        11.12.2 Lupin Overview
        11.12.3 Lupin Tadalafil Oral Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Lupin Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Lupin Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Tadalafil Oral Industry Chain Analysis
    12.2 Tadalafil Oral Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Tadalafil Oral Production Mode & Process
    12.4 Tadalafil Oral Sales and Marketing
        12.4.1 Tadalafil Oral Sales Channels
        12.4.2 Tadalafil Oral Distributors
    12.5 Tadalafil Oral Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Tadalafil Oral Industry Trends
    13.2 Tadalafil Oral Market Drivers
    13.3 Tadalafil Oral Market Challenges
    13.4 Tadalafil Oral Market Restraints
14 Key Findings in The Global Tadalafil Oral Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Tadalafil Oral Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 2.5 mg tablets
    Table 3. Major Manufacturers of 5 mg tablets
    Table 4. Major Manufacturers of 10mg tablets
    Table 5. Major Manufacturers of 20 mg tablets
    Table 6. Global Tadalafil Oral Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Tadalafil Oral Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Tadalafil Oral Sales by Region (2017-2022) & (K Units)
    Table 9. Global Tadalafil Oral Sales Market Share by Region (2017-2022)
    Table 10. Global Tadalafil Oral Sales by Region (2023-2028) & (K Units)
    Table 11. Global Tadalafil Oral Sales Market Share by Region (2023-2028)
    Table 12. Global Tadalafil Oral Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Tadalafil Oral Revenue Market Share by Region (2017-2022)
    Table 14. Global Tadalafil Oral Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Tadalafil Oral Revenue Market Share by Region (2023-2028)
    Table 16. Global Tadalafil Oral Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Tadalafil Oral Sales Share by Manufacturers (2017-2022)
    Table 18. Global Tadalafil Oral Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Tadalafil Oral Revenue Share by Manufacturers (2017-2022)
    Table 20. Tadalafil Oral Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Tadalafil Oral Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Tadalafil Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tadalafil Oral as of 2021)
    Table 23. Tadalafil Oral Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Tadalafil Oral Product Offered
    Table 25. Date of Manufacturers Enter into Tadalafil Oral Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 28. Global Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 29. Global Tadalafil Oral Sales Share by Type (2017-2022)
    Table 30. Global Tadalafil Oral Sales Share by Type (2023-2028)
    Table 31. Global Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Tadalafil Oral Revenue Share by Type (2017-2022)
    Table 34. Global Tadalafil Oral Revenue Share by Type (2023-2028)
    Table 35. Tadalafil Oral Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Tadalafil Oral Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 38. Global Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 39. Global Tadalafil Oral Sales Share by Application (2017-2022)
    Table 40. Global Tadalafil Oral Sales Share by Application (2023-2028)
    Table 41. Global Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Tadalafil Oral Revenue Share by Application (2017-2022)
    Table 44. Global Tadalafil Oral Revenue Share by Application (2023-2028)
    Table 45. Tadalafil Oral Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Tadalafil Oral Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 48. North America Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 49. North America Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 52. North America Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 53. North America Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Tadalafil Oral Sales by Country (2017-2022) & (K Units)
    Table 56. North America Tadalafil Oral Sales by Country (2023-2028) & (K Units)
    Table 57. North America Tadalafil Oral Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Tadalafil Oral Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Tadalafil Oral Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Tadalafil Oral Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Tadalafil Oral Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Tadalafil Oral Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Tadalafil Oral Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Tadalafil Oral Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Tadalafil Oral Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Tadalafil Oral Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Tadalafil Oral Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Tadalafil Oral Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Tadalafil Oral Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Tadalafil Oral Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Tadalafil Oral Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Tadalafil Oral Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Tadalafil Oral Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Tadalafil Oral Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Tadalafil Oral Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Tadalafil Oral Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Tadalafil Oral Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Tadalafil Oral Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Tadalafil Oral Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Tadalafil Oral Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Tadalafil Oral Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Tadalafil Oral Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Eli Lilly Corporation Information
    Table 108. Eli Lilly Description and Major Businesses
    Table 109. Eli Lilly Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Eli Lilly Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Eli Lilly Recent Developments
    Table 112. Teva Corporation Information
    Table 113. Teva Description and Major Businesses
    Table 114. Teva Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Teva Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Teva Recent Developments
    Table 117. Aurobindo Corporation Information
    Table 118. Aurobindo Description and Major Businesses
    Table 119. Aurobindo Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Aurobindo Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Aurobindo Recent Developments
    Table 122. Sun Pharma Corporation Information
    Table 123. Sun Pharma Description and Major Businesses
    Table 124. Sun Pharma Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Sun Pharma Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Sun Pharma Recent Developments
    Table 127. Alembic Pharmaceuticals Corporation Information
    Table 128. Alembic Pharmaceuticals Description and Major Businesses
    Table 129. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Alembic Pharmaceuticals Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Alembic Pharmaceuticals Recent Developments
    Table 132. Mylan Corporation Information
    Table 133. Mylan Description and Major Businesses
    Table 134. Mylan Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Mylan Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Mylan Recent Developments
    Table 137. Accord Healthcare Corporation Information
    Table 138. Accord Healthcare Description and Major Businesses
    Table 139. Accord Healthcare Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Accord Healthcare Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Accord Healthcare Recent Developments
    Table 142. Cipla Corporation Information
    Table 143. Cipla Description and Major Businesses
    Table 144. Cipla Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Cipla Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Cipla Recent Developments
    Table 147. Ajanta Pharma Ltd. Corporation Information
    Table 148. Ajanta Pharma Ltd. Description and Major Businesses
    Table 149. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Ajanta Pharma Ltd. Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Ajanta Pharma Ltd. Recent Developments
    Table 152. Dr. Reddys Laboratories Corporation Information
    Table 153. Dr. Reddys Laboratories Description and Major Businesses
    Table 154. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Dr. Reddys Laboratories Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Dr. Reddys Laboratories Recent Developments
    Table 157. Qilu Pharmaceutical Corporation Information
    Table 158. Qilu Pharmaceutical Description and Major Businesses
    Table 159. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Qilu Pharmaceutical Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Qilu Pharmaceutical Recent Developments
    Table 162. Lupin Corporation Information
    Table 163. Lupin Description and Major Businesses
    Table 164. Lupin Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Lupin Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Lupin Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Tadalafil Oral Distributors List
    Table 170. Tadalafil Oral Customers List
    Table 171. Tadalafil Oral Market Trends
    Table 172. Tadalafil Oral Market Drivers
    Table 173. Tadalafil Oral Market Challenges
    Table 174. Tadalafil Oral Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tadalafil Oral Product Picture
    Figure 3. Global Tadalafil Oral Market Share by Type in 2021 & 2028
    Figure 3. 2.5 mg tablets Product Picture
    Figure 4. 5 mg tablets Product Picture
    Figure 5. 10mg tablets Product Picture
    Figure 6. 20 mg tablets Product Picture
    Figure 7. Global Tadalafil Oral Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Drug store
    Figure 10. Tadalafil Oral Report Years Considered
    Figure 11. Global Tadalafil Oral Sales 2017-2028 (K Units)
    Figure 12. Global Tadalafil Oral Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Tadalafil Oral Revenue 2017-2028 (US$ Million)
    Figure 14. Global Tadalafil Oral Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Tadalafil Oral Sales Market Share by Region (2017-2022)
    Figure 16. Global Tadalafil Oral Sales Market Share by Region (2023-2028)
    Figure 17. North America Tadalafil Oral Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Tadalafil Oral Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Tadalafil Oral Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Tadalafil Oral Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Tadalafil Oral Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Tadalafil Oral Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Tadalafil Oral Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Tadalafil Oral Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Tadalafil Oral Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Tadalafil Oral Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Tadalafil Oral Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Tadalafil Oral in the World: Market Share by Tadalafil Oral Revenue in 2021
    Figure 29. Global Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 31. Global Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 32. Global Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 33. Global Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 34. North America Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 35. North America Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 36. North America Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 37. North America Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 38. North America Tadalafil Oral Sales Share by Country (2017-2028)
    Figure 39. North America Tadalafil Oral Revenue Share by Country (2017-2028)
    Figure 40. U.S. Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 43. Europe Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 45. Europe Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Tadalafil Oral Sales Share by Country (2017-2028)
    Figure 47. Europe Tadalafil Oral Revenue Share by Country (2017-2028)
    Figure 48. Germany Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 49. France Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Tadalafil Oral Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Tadalafil Oral Revenue Share by Region (2017-2028)
    Figure 59. China Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 62. India Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Tadalafil Oral Sales Share by Country (2017-2028)
    Figure 74. Latin America Tadalafil Oral Revenue Share by Country (2017-2028)
    Figure 75. Mexico Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Tadalafil Oral Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Tadalafil Oral Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Tadalafil Oral Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Tadalafil Oral Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Tadalafil Oral Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Tadalafil Oral Revenue Share by Country (2017-2028)
    Figure 84. Turkey Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Tadalafil Oral Revenue (2017-2028) & (US$ Million)
    Figure 87. Tadalafil Oral Value Chain
    Figure 88. Tadalafil Oral Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed